Literature DB >> 11837707

Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD).

Craig W Hayden1, Charles N Bernstein, Renée A Hall, Nimish Vakil, Harinder S Garewal, Ronnie Fass.   

Abstract

There is an increasing trend towards alternative medicine usage by the general US population. However, the extent and type of supplemental alternative medicine used specifically by community-based patients with GERD is unknown. A previously validated questionnaire that included questions about patient demographics, 18 types of alternative medicine, and attitudes towards alternative and conventional medicine was utilized. Consecutive patients seen by community-based physicians in Arizona (Tucson, Phoenix, and Flagstaff) and Wisconsin (Milwaukee) for GERD received the questionnaire during the years 1999 and 2000. Patients completed the questionnaire and returned it to the Tucson VA Medical Center by mail. A total of 185 patients were surveyed (82 men, mean age 55.8 years). Of those, 61.6% used alternative medicine for any reason. However, only 3.8% of patients used supplemental alternative medicine for GERD. Females were twice as likely (95% CI, 1.10-3.67) to use alternative medicines for any reason (including GERD). Patients with daily acid regurgitation were 5.75 times (95% CI, 1.03-32.17) more likely than patients with less frequent acid regurgitation to use alternative medicines specifically for GERD. None of the other demographics, health characteristics, or attitudes were predictive of supplemental alternative medicine use for any reason (or specifically for GERD). In conclusion, only a small percentage of GERD patients seen by community-based practitioners use supplemental alternative medicine specifically for GERD symptoms, despite a higher usage of supplemental alternative medicine for non-GERD-related illness. Being female and having acid regurgitation daily were positively associated with alternative medicine usage for GERD.

Entities:  

Mesh:

Year:  2002        PMID: 11837707     DOI: 10.1023/a:1013264730992

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  8 in total

1.  Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome.

Authors:  R H Corney; R Stanton
Journal:  J Psychosom Res       Date:  1990       Impact factor: 3.006

Review 2.  Alternative therapies, 1990. An overview.

Authors:  L S McGinnis
Journal:  Cancer       Date:  1991-03-15       Impact factor: 6.860

3.  As their health improves, British broaden quest for alternative health care.

Authors:  C Richmond
Journal:  CMAJ       Date:  1991-04-01       Impact factor: 8.262

4.  Physicians and healers--unwitting partners in health care.

Authors:  R H Murray; A J Rubel
Journal:  N Engl J Med       Date:  1992-01-02       Impact factor: 91.245

Review 5.  Contemporary medical therapy for gastroesophageal reflux disease.

Authors:  R Fass; L J Hixson; M L Ciccolo; P Gordon; G Hunter; W Rappaport
Journal:  Am Fam Physician       Date:  1997-01       Impact factor: 3.292

6.  A new questionnaire for gastroesophageal reflux disease.

Authors:  G R Locke; N J Talley; A L Weaver; A R Zinsmeister
Journal:  Mayo Clin Proc       Date:  1994-06       Impact factor: 7.616

7.  An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease.

Authors:  P Rawsthorne; F Shanahan; N C Cronin; P A Anton; R Löfberg; L Bohman; C N Bernstein
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

8.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

  8 in total
  3 in total

1.  Banxia Xiexin tang for gastro-oesophageal reflux disease: A protocol for a systematic review of controlled trials.

Authors:  Bohyung Kang; Haesol Lee; Youkyung Choi; Chanyong Jeon; Ju Ah Lee
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

2.  Alternative vs. conventional treatment given on-demand for gastroesophageal reflux disease: a randomised controlled trial.

Authors:  Per G Farup; Mathis Heibert; Victor Høeg
Journal:  BMC Complement Altern Med       Date:  2009-02-24       Impact factor: 3.659

3.  Electroacupuncture to treat gastroesophageal reflux disease: study protocol for a randomized controlled trial.

Authors:  Gajin Han; Jungtae Leem; Hojung Lee; Junhee Lee
Journal:  Trials       Date:  2016-05-17       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.